Medinotec Inc. (MDNC) stock
MDNCOTCSurgical & Medical Instruments & ApparatusFiscal year ends February 28
$5.00+0.00 (0.00%)
Close on Oct 16, 2026Market cap $58.78MP/E –Yield –
Medinotec r&d expenses
Research and development expenses are spending on new products and technology.
Medinotec's R&D Expenses for the twelve months ending Aug 31, 2026 was $64.66K, down 65.9% year over year. For fiscal 2026 it was $149.86K, up 64.4% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Feb 28, 2026 | $149.86K | +64.4% |
| FY2025 | Feb 28, 2025 | $91.13K | – |
| FY2024 | Feb 29, 2024 | -$22.35K | – |
| FY2023 | Feb 28, 2023 | -$64.87K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Aug 31, 2026 | $22.08K | -66.7% |
| Q1 FY2027CQ2 2026 | May 31, 2026 | $7.97K | -83.7% |
| Q4 FY2026CQ1 2026 | Feb 28, 2026 | $26.28K | +426.6% |
| Q3 FY2026CQ4 2025 | Nov 30, 2025 | $8.33K | -88.0% |
| Q2 FY2026CQ3 2025 | Aug 31, 2025 | $66.24K | +3400.8% |
| Q1 FY2026CQ2 2025 | May 31, 2025 | $49.01K | – |
| Q4 FY2025CQ1 2025 | Feb 28, 2025 | $4.99K | +83.0% |
| Q3 FY2025CQ4 2024 | Nov 30, 2024 | $69.27K | +484.2% |
| Q2 FY2025CQ3 2024 | Aug 31, 2024 | $1.89K | – |
| Q1 FY2025CQ2 2024 | May 31, 2024 | -$14.98K | -696.9% |
| Q3 FY2024CQ4 2023 | Nov 30, 2023 | $2.73K | -57.4% |
| Q2 FY2024CQ3 2023 | Aug 31, 2023 | $11.86K | -45.8% |
| Q1 FY2024CQ2 2023 | May 31, 2023 | -$2.26K | – |
| Q4 FY2023CQ1 2023 | Feb 28, 2023 | $2.51K | – |
| Q3 FY2023CQ4 2022 | Nov 30, 2022 | $6.41K | – |
| Q2 FY2023CQ3 2022 | Aug 31, 2022 | $21.89K | – |
| Q1 FY2023CQ2 2022 | May 31, 2022 | -$34.06K | – |
See a number that looks wrong?